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Detection of humoral response using a recombinant heat shock
protein 70, DnaK, of Mycoplasma haemofelis in experimentally
and naturally hemoplasma-infected cats
Abstract
Hemoplasmas is the trivial name given to a group of erythrocyte-parasitizing bacteria of the genus
Mycoplasma. Of the feline hemoplasmas, Mycoplasma haemofelis is the most pathogenic, while
"Candidatus Mycoplasma haemominutum" and "Candidatus Mycoplasma turicensis" are less
pathogenic. Shotgun libraries of fragmented M. haemofelis genomic DNA were constructed, and
random colonies were selected for DNA sequencing. In silico-translated amino acid sequences of
putative open reading frames were compared to mass spectrometry data from M. haemofelis protein
spots identified as being immunogenic by two-dimensional gel electrophoresis and Western blotting.
Three of the spots matched the predicted sequences of a heat shock protein 70 (DnaK) homolog,
elongation factor Ts, and a fragment of phosphoglycerate kinase found during library screening. A
full-length copy of the M. haemofelis dnaK gene was cloned into Escherichia coli and recombinantly
expressed. Recombinant M. haemofelis DnaK was purified and then used in Western blotting and an
enzyme-linked immunosorbent assay (ELISA) to investigate the humoral immune response during acute
infection in cats experimentally infected with M. haemofelis, "Ca. Mycoplasma haemominutum," or
"Ca. Mycoplasma turicensis". The recombinant M. haemofelis DnaK ELISA also was used to screen
clinical samples submitted for hemoplasma PCR testing to a commercial laboratory (n = 254).
Experimentally infected cats became seropositive following infection, with a greater and earlier
antibody response seen in cats inoculated with M. haemofelis than those seen in cats inoculated with
"Ca. Mycoplasma haemominutum" or "Ca. Mycoplasma turicensis," by both Western blotting and
ELISA. Of the clinical samples, 31.1% had antibodies detected by the ELISA but only 9.8% were
positive by PCR for one or more hemoplasmas.
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Hemoplasmas is the trivial name given to a group of erythrocyte-parasitizing bacteria of the genus
Mycoplasma. Of the feline hemoplasmas, Mycoplasma haemofelis is the most pathogenic, while “Candidatus
Mycoplasma haemominutum” and “Candidatus Mycoplasma turicensis” are less pathogenic. Shotgun
libraries of fragmented M. haemofelis genomic DNA were constructed, and random colonies were selected
for DNA sequencing. In silico-translated amino acid sequences of putative open reading frames were
compared to mass spectrometry data from M. haemofelis protein spots identified as being immunogenic by
two-dimensional gel electrophoresis and Western blotting. Three of the spots matched the predicted
sequences of a heat shock protein 70 (DnaK) homolog, elongation factor Ts, and a fragment of phospho-
glycerate kinase found during library screening. A full-length copy of the M. haemofelis dnaK gene was
cloned into Escherichia coli and recombinantly expressed. Recombinant M. haemofelis DnaK was purified
and then used in Western blotting and an enzyme-linked immunosorbent assay (ELISA) to investigate the
humoral immune response during acute infection in cats experimentally infected with M. haemofelis, “Ca.
Mycoplasma haemominutum,” or “Ca. Mycoplasma turicensis”. The recombinant M. haemofelis DnaK
ELISA also was used to screen clinical samples submitted for hemoplasma PCR testing to a commercial
laboratory (n  254). Experimentally infected cats became seropositive following infection, with a greater
and earlier antibody response seen in cats inoculated with M. haemofelis than those seen in cats inoculated
with “Ca. Mycoplasma haemominutum” or “Ca. Mycoplasma turicensis,” by both Western blotting and
ELISA. Of the clinical samples, 31.1% had antibodies detected by the ELISA but only 9.8% were positive
by PCR for one or more hemoplasmas.
Hemoplasmas is the trivial name given to a group of eryth-
rocyte-parasitizing bacteria of the genus Mycoplasma within
the Mollicutes class, following their reclassification from the
Haemobartonella and Eperythrozoon genera (6). In the United
Kingdom, three feline hemoplasmas have been documented:
Mycoplasma haemofelis, “Candidatus Mycoplasma haemo-
minutum,” and “Candidatus Mycoplasma turicensis” (8, 10,
19). Clinical signs of hemoplasma infection range from asymp-
tomatic to mild pyrexia to life-threatening (and occasionally
fatal) hemolytic anemia even in immunocompetent individuals
(9). Of the feline hemoplasmas, M. haemofelis appears to be
most significant in terms of inducing hemolysis. Cats can re-
main infected with hemoplasmas in the absence of clinical
signs, for months to years, and therefore they can represent a
reservoir of infection (2, 17). This “carrier” status appears to
be more commonly encountered with “Ca. Mycoplasma ha-
emominutum” and less so with M. haemofelis, which could
contribute to the differences in prevalences reported for these
hemoplasma species (11, 12, 18).
The diagnosis of hemoplasma infection originally was based
on clinical signs and the visualization of epierythrocytic bodies
by light microscopic examination of blood smears. More re-
cently, PCR technology has superseded cytology for diagnosis
due to its superior sensitivity and specificity (13, 16). The
diagnosis of hemoplasma infection status using PCR is, how-
ever, not completely optimal. PCR results become negative
when hemoplasma copy numbers fall below the detection limit
of the assay. This may occur despite cats still being hemo-
plasma infected, such as in some carrier cats or following
antibiotic treatment (12, 14). PCR testing of blood also re-
quires the submission of a blood sample to a specialist labo-
ratory, with associated cost implications in terms of both time
and money, whereas a number of enzyme-linked immunosor-
bent assay (ELISAs) have been developed for point-of-care
use in general practice, for example, the SNAP ELISAs (Idexx
Labs.).
The ideal serological assay for hemoplasma infection
would be both specific and sensitive at identifying hemo-
plasma-infected cats, and it would differentiate acute from
chronic infection. The lack of in vitro cultivation techniques
for hemoplasmas has limited the use of whole-hemoplasma
preparations in serological assays. Recently a 299-amino-
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acid fragment of M. haemofelis heat shock protein 70
(DnaK) was recombinantly expressed and used in prelimi-
nary Western blot analyses to detect the presence of anti-
DnaK antibodies in three cats experimentally infected with
M. haemofelis, “Ca. Mycoplasma haemominutum,” or “Ca.
Mycoplasma turicensis” (5). The further use of this assay in
cats at different time points of hemoplasma infection or on
samples obtained from clinical cases has not been reported.
In the current study, we describe the detection and identi-
fication of immunogenic proteins of a feline hemoplasma, with
the characterization of the immune response to one of these
proteins. M. haemofelis genomic DNA (gDNA) shotgun librar-
ies were constructed and random clones analyzed to generate
partial genome sequence coverage. Three in silico-translated
amino acids predicted from these libraries were found to
match mass spectrometry data pertaining to three immuno-
genic M. haemofelis protein spots identified using two-dimen-
sional electrophoresis and Western blotting. The genes encod-
ing these proteins were cloned and expressed in Escherichia
coli. Purified recombinant M. haemofelis DnaK subsequently
was used in one-dimensional Western blot analyses and
ELISAs for the detection of reactive anti-DnaK antibodies in
experimentally infected cats during acute infection and in clin-
ical samples submitted for hemoplasma quantitative PCR
(qPCR) to a commercial laboratory.
MATERIALS AND METHODS
Feline plasma samples. Remaining plasma from samples collected from 16
specific-pathogen-free (SPF)-derived cats in a previous feline hemoplasma study
were used in this study (14, 15). Ten cats had been infected experimentally with
M. haemofelis, three with “Ca. Mycoplasma haemominutum,” and three with
“Ca. Mycoplasma turicensis” (M. haemofelis-infected cats were designated HF1,
HF2, HF3, HF4, HF6, HF7, HF8, HF9, HF10, and HF12; “Ca. Mycoplasma
haemominutum”-infected cats were HM1, HM2, and HM4; “Ca. Mycoplasma
turicensis”-infected cats were TU1, TU2, and TU4). The plasma samples had
been derived from 1-ml samples of EDTA-anticoagulated whole blood by cen-
trifugation at 2,200 g for 3 min and had been stored at20°C until use. Plasma
samples were available for both pre- and postinfection time points; for all cats,
plasma was available from 8, 15, 22, 29, 36, 43, 50, 57, 64, and 71 days postin-
fection (dpi), and additional plasma was available for cats HF4 and HF8 from
139, 153, and 177 dpi.
Excess EDTA-anticoagulated blood, available from samples submitted to the
Diagnostic Laboratories, Langford Veterinary Services, University of Bristol, for
feline hemoplasma qPCR testing between November 2009 and May 2010 were
collected. Samples were centrifuged (2,200  g, 3 min) and the plasma removed.
The samples that generated at least 100 l of plasma were stored at 20°C until
use. Previously determined hemoplasma qPCR results were available for all
blood samples. Hematology results were available for the experimental blood
samples.
Sources of M. haemofelis DNA and protein and feline red blood cell membrane
ghosts. Preparations of M. haemofelis had been previously purified from blood
taken from cat HF14 at a time of high parasitemia on 11 dpi (7). Briefly, M.
haemofelis organisms were dislodged from the surface of phosphate-buffered
saline (PBS; 137 mM NaCl, 1.47 mM KH2PO4, 10 mM Na2HPO4, 2.7 mM KCl,
pH 7.0)-washed erythrocytes using 3% (wt/vol) EDTA and 0.15% (vol/vol)
Tween 20 in PBS. The erythrocytes and debris were separated from the M.
haemofelis organisms in suspension by low-speed centrifugation (600  g, 10
min). The supernatant then was subjected to high-speed centrifugation to pellet
the suspended hemoplasmas (40,000  g, 30 min, 4°C). The resultant superna-
tant was determined, by qPCR (8), to be rich in M. haemofelis DNA, which was
assumed to be the result of M. haemofelis cell lysis releasing free gDNA. This
gDNA was purified and concentrated using the Macherey-Nagel Nucleospin
blood kit (ABgene, Epson, United Kingdom) for use in genomic studies. The
high-speed pellet of M. haemofelis was subjected to differential gradient centrif-
ugation and subsequently concentrated using a 9-kDa molecular mass cutoff filter
for use in proteomic studies. A similar protein preparation protocol was per-
formed on uninfected feline red blood cells (RBCs) to obtain RBC membrane
ghosts, as described previously (7).
Generation of M. haemofelis shotgun libraries. For genomic studies, shotgun
clone libraries of purified M. haemofelis gDNA were generated using the TOPO
shotgun subcloning kit (Invitrogen, Paisley, United Kingdom). Initially gDNA
was sheared by nebulization into 2- to 5-kbp fragments, as determined by gel
electrophoresis. These fragments then were blunt ended and ligated into
pCR4Blunt-TOPO and transformed into one-shot chemically competent E. coli.
Purified plasmids from randomly selected clones were sequenced using plasmid
primers and, where the insert length was greater than 900 bp, internal sequencing
primers. DNA sequencing was performed by DNA Sequencing and Services
(University of Dundee, Scotland; www.dnaseq.co.uk) using Applied Biosystems
Big-Dye version 3.1 chemistry on an Applied Biosystems model 3730 automated
capillary DNA sequencer (Applied Biosystems, Foster City, CA). BLASTn and
BLASTp analyses of nucleotide and corresponding predicted amino-acid se-
quences were performed to identify the origin of the insert sequences (http:
//blast.ncbi.nlm.nih.gov/Blast.cgi) (1). Gene sequences were translated using the
Mycoplasma/Spiroplasma codon usage table. Custom primers designed to mar-
gins of known M. haemofelis sequence data were used in conjunction with
plasmid primers to obtain contiguous sequences by PCR using the M. haemofelis
libraries as the template.
Identification of M. haemofelis immunogenic proteins. For proteomic studies,
the M. haemofelis and RBC membrane ghost protein preparations were prepared
for two-dimensional (2D) SDS-PAGE using the 2D clean-up kit (GE Health-
care, Amersham Place, Little Chalfont, United Kingdom). Proteins were sepa-
rated according to their isoelectric points on Immobiline DryStrip pH 3-11 NL
(GE Healthcare) and then according to mass (12.5% polyacrylamide gel) along-
side a molecular weight marker (unstained or All Blue Precision Plus Protein
Standards; Bio-Rad Laboratories Ltd., Hemel Hempstead, United Kingdom).
Gels either were subjected to Western blotting on polyvinylidene difluoride
(PVDF) membranes or stained using Sypro ruby protein gel stain (Invitrogen).
Membranes were blocked by gentle agitation for 5 h in Tris-buffered saline (25
mM Tris, 150 mM NaCl, pH 7.6) with Tween 20 (0.1%, vol/vol) and 5% (wt/vol)
nonfat milk powder (TBST-5 M; Marvel, Premier Foods). Membranes were
incubated overnight with preinfection or postinfection (139 and 153 dpi) plasma
combined from two cats (HF4 and HF8) diluted 1:500 in TBST-5 M. Washed
membranes then were incubated for 2 h at room temperature in TBST-5 M
containing a 1:20,000 dilution of alkaline phosphatase-conjugated goat anti-cat
IgG (HL) antibody (Jackson ImmunoResearch Europe Ltd.). Membranes
were washed in Tris-buffered saline (25 mM Tris, 150 mM NaCl) with Tween 20
(0.1% vol/vol) (TBST) between steps (20 min; two wash changes; orbital shaker
at 25 rpm and room temperature). Following the final washes, visualization was
achieved by the exposure of Amersham Hyperfilm ECL (GE Healthcare) to
membranes coated with Lumi-Phos WB chemiluminescent substrate (Pierce
Biotechnology, Thermo Fisher Scientific, Cramlington, United Kingdom). From
the Sypro ruby-stained gel, protein spots corresponding to spots of immunore-
activity were picked for trypsin digestion, and the resulting peptides were ana-
lyzed using mass spectrometry (4700 MALDI-TOF/TOF mass spectrometer;
Applied Biosystems). Results were analyzed in Mascot (www.matrixscience.com)
and compared to known M. haemofelis sequences derived from the shotgun
libraries and to the NCBInr protein database.
Cloning and expression of recombinant M. haemofelis DnaK. The full-length
M. haemofelis dnaK gene sequence was cloned into pET101/D-TOPO and ex-
pressed in BL21 Star (DE3) E. coli as a fusion protein with a C-terminal 6-His
tag using the Champion pET directional TOPO kit (Invitrogen). His-tagged
recombinant M. haemofelis DnaK was purified under denaturing conditions using
the Ni-NTA spin kit (Qiagen, Crawley, United Kingdom). Protein levels were
quantified using the Quant-iT protein assay kit (Invitrogen). Purified recombi-
nant M. haemofelis DnaK was subjected to one-dimensional SDS-PAGE
(NuPAGE Novex Bis-Tris gel system; Invitrogen) and stained with Coomassie
blue R-250, and its mass was determined by comparison to a molecular size
ladder (All Blue Precision Plus Protein Standards). The band at approximately
70 kDa, along with two minor bands at approximately 32 and 12 kDa, were
excised from the gel and subjected to trypsin digestion and mass spectrometry
(4700 MALDI-TOF/TOF mass spectrometer).
Investigation of the humoral immune response to recombinant M. haemofelis
DnaK in experimentally infected cats using one-dimensional Western blotting.
The one-dimensional PAGE of recombinant M. haemofelis DnaK (35 ng/well)
under reducing conditions was performed using NuPAGE Novex 4 to 12%
Bis-Tris precast gels, NuPAGE morpholinepropanesulfonic acid (MOPS) run-
ning buffer, and NuPAGE LDS sample buffer (all Invitrogen). Proteins were
transferred to 0.45-m-pore-size nitrocellulose membranes using the XCell
mini-cell and blot module and NuPAGE transfer buffer per the manufacturer’s
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instructions (all from Invitrogen). A prestained molecular size standard (All Blue
Precision Plus Protein Standards) was included on each gel to monitor transfer
efficiency.
Western blotting was carried out as described previously with the following
modifications: membranes were blocked for 2 h, followed by being probed with
preinfection plasma from 10 cats (HF1, HF2, HF3, HF4, HF6, HF7, HF8, HF9,
HF10, and HF12) and postinfection plasma from all 16 cats from 29 dpi at a
1:250 dilution.
Development of a recombinant M. haemofelis DnaK ELISA. Vinyl flat-bottom
microtiter plates (Thermo Fisher Scientific) were coated with dilutions of re-
combinant M. haemofelis DnaK in a volume of 100 l sodium carbonate buffer
(0.05 M, pH 9.6) and incubated overnight at 4°C. Wells contained 692, 346, 173,
86.5, 43.3, 21.6, 10.8, or 5.4 ng recombinant M. haemofelis DnaK, with control
wells containing no recombinant protein included on each test plate. Plates were
washed with PBS containing 0.05% (vol/vol) Tween 20 (PBST), blocked using
PBST containing 10% (wt/vol) fat-free milk powder (PBST-10 M; Marvel) for 2 h
at room temperature with agitation and then washed with PBST. Wells of each
recombinant M. haemofelis DnaK dilution were incubated in duplicate with 100
l preinfection plasma (HF4) diluted 1:200 in PBST-10 M and 100 l postin-
fection plasma (HF4; 174 dpi) diluted (1:200, 1:400, and 1:800) in PBST-10 M for
2 h at room temperature with agitation and then washed with PBST. Wells then
were incubated with 100 l alkaline phosphatase-conjugated goat anti-cat IgG
(HL) at a 1:10,000 or 1:20,000 dilution in PBST-10 M for 2 h at room tem-
perature with agitation and then washed with PBST. Wells then were incubated
with p-nitrophenyl phosphate (pNPP; 100 l/well; 1 mg/ml in sodium carbonate
buffer, 0.05 M, pH 9.6) in the dark. Optical density at 405 and 495 nm (OD405–
495) was measured using a computer-assisted microplate reader (Labsystems
Multiscan Ex Primary EIA v2.1-0 with Genesis v3.0; VWR International Ltd.,
Lutterworth, United Kingdom) at 30, 45, 60, 75, and 90 min.
Screening of feline plasma using an ELISA of recombinant M. haemofelis
DnaK. To screen the plasma samples, ELISA was performed as described above
with plates coated with 14 ng/well recombinant M. haemofelis DnaK, the sec-
ondary antibody used at a 1:10,000 dilution in PBST-10 M, and the plates read
at 75 to 80 min. Pre- and postinfection plasma (8, 15, 22, 29, 36, 43, 50, 57, 64,
and 71 dpi) from all 16 experimentally infected cats were tested, as well as plasma
from the feline clinical samples.
Each plate contained wells to which (i) no plasma was added (in triplicate), (ii)
preinfection plasma from HF4 (1:200, 1:400 and 1:800 dilutions) was added, and
(iii) duplicate 2-fold serial dilutions of a strong hemoplasma-positive (HF6;
pooled plasma at 15, 22, and 29 dpi) feline plasma standard (1:200 to 1:409,600)
was added. Samples were deemed positive if their average OD405–495 value for
the 1:200 dilution was greater than three standard deviations above the mean
value of results obtained from the preinfection experimental cat plasma. At 75
min, ODs obtained from the samples were plotted against the log of the dilu-
tions, and relative antibody levels (RAL) were calculated by comparison to the
standard dilution series if sample results lay within the linear portion of the plot,
with the undiluted standard being assigned a RAL of 10,000.
Data were explored by plotting each peak of hemoplasma copy number and
nadir of packed cell volume (PCV) against maximum RAL for each M. haemofe-
lis-infected cat, and correlation was assessed using the Spearman’s rank corre-
lation test, using Predictive Analytics SoftWare (PASW) Statistics Package, ver-
sion 17. Significance was taken at P  0.05.
RESULTS
M. haemofelis shotgun libraries. M. haemofelis gDNA was
successfully extracted and shotgun cloned into E. coli. A ran-
dom screening of the library and DNA sequencing identified a
1,809-bp sequence that encoded the entire gene of putative
heat shock protein 70 (dnaK; HQ013311), with 99.2% identity
to a partial fragment of the M. haemofelis dnaK gene
(FJ463263), 82.1% identity to a partial fragment of Myco-
plasma haemocanis dnaK (AY150992), and 72.8% identity to
the Mycoplasma suis a1 gene (AM265536). The translation of
this nucleotide sequence gave a 602-amino-acid protein
(ADN05760) with a predicted mass of 65.6 kDa and 99.6%
identity (99.6% similarity) to a partial fragment of M. haemofe-
lis dnaK (ACO07298), 91.3% identity (95.2% similarity) to a
partial fragment of M. haemocanis dnaK (AAN37401), and
71.0% identity (84.8% similarity) to heat shock protein A1 of
M. suis (CAK22359). Library screening also identified the en-
tire gene of putative elongation factor Ts (EF-Ts; HQ267766)
and a partial 5 fragment of putative phosphoglycerate kinase
(pgk; HQ267765). Both EF-Ts and pgk genes contained opal
codons, unlike the M. haemofelis dnaK gene. The M. haemofelis
pgk gene fragment had 78% identity to the pgk gene of Myco-
plasma agalactiae (FP671138), while the M. haemofelis EF-Ts
gene did not significantly match any mollicute sequences in the
database. The translation of the M. haemofelis EF-Ts gene
gave a 277-amino-acid protein with a predicted mass of 30.8
kDa and 37% identity (57% similarity) to EF-Ts of Myco-
plasma gallisepticum (NP_852870). The translation of the par-
tial M. haemofelis pgk sequence gave a 343-amino-acid peptide
fragment with 50% identity (71% similarity) to pgk of Meso-
plasma florum (YP_053819).
Immunogenic M. haemofelis proteins identified from 2-di-
mensional Western blot. A number of spots were present on
the 2D M. haemofelis Western blot probed with postinfection
plasma (Fig. 1) that were not present on the blot probed with
preinfection plasma or on the RBC membrane ghost Western
blot probed with postinfection plasma. Twenty-one of these
spots corresponded to visible protein spots on the Sypro ruby-
stained 2D gel and therefore could be analyzed by tandem
mass spectrometry (Fig. 2). Peptide mass fingerprint data and
tandem mass spectra for three spots significantly (score, 20)
FIG. 1. Mycoplasma haemofelis protein preparation separated by
two-dimensional electrophoresis and subjected to Western blotting
with pooled postinfection plasma. The immunogenic spots correspond-
ing to DnaK (D), pgk (P), and EF-Ts (E) are indicated by the circles.
The pH orientation and three molecular mass markers (All Blue Pre-
cision Plus Protein Standard; Bio-Rad) are indicated.
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matched predicted amino acid sequence data; one spot corre-
sponded to the predicted complete M. haemofelis DnaK (score
of 77, including spectra of two peptide mass peaks, at 1,744.9
and 1,581.8 Da), another to the complete M. haemofelis EF-Ts
(score of 85; one peptide mass peak, at 1,256.6 Da), and the
predicted partial fragment of pgk (score of 97; four peptide
mass peaks, at 2,154.0, 1,562.9, 1,057.6, and 1,012.6 Da).
Expression of recombinant M. haemofelis DnaK. Recombi-
nant M. haemofelis DnaK was successfully expressed in E. coli
and purified by Ni-NTA chromatography using the C-terminal
His tag. The recombinant protein was seen as a band at ap-
proximately 70 kDa on PAGE (Fig. 3) and was confirmed by
mass spectrometry to be DnaK (protein score, 962; a score of
44 was significant). The two smaller bands at 32 and 12 kDa
also were identified by mass spectrometry as C-terminal break-
down fragments of DnaK. The expression of M. haemofelis pgk
(partial) and M. haemofelis EF-Ts was attempted following the
site-directed mutagenesis of both genes to remove opal codons
(data not shown). However, the expression efficiency was low,
resulting in insufficient protein being available for Western
blotting and ELISAs.
Humoral immune response to recombinant M. haemofelis
DnaK by experimentally infected cats on one-dimensional
Western blotting. Recombinant M. haemofelis DnaK did not
react to Western blotting with preinfection plasma from any of
the experimental cats tested. Postinfection plasma (29 dpi)
Western blotting of recombinant M. haemofelis DnaK demon-
strated positive bands at approximately 70 kDa (full-length
protein) and occasionally at 32 kDa (breakdown fragment) for
all 10 cats infected with M. haemofelis (Fig. 4 is a representa-
tive blot), as well as bands at approximately 70 kDa in all three
“Ca. Mycoplasma turicensis”-infected cats and in two out of
three cats infected with “Ca. Mycoplasma haemominutum”.
The “Ca. Mycoplasma haemominutum”-infected cat with a
negative Western blot at 29 dpi became positive by 36 dpi (data
not shown). Plasma from the M. haemofelis-infected cats pro-
duced a stronger signal than the plasma from “Ca. Myco-
plasma haemominutum”- and “Ca. Mycoplasma turicensis”-
infected cats (data not shown).
Development and use of a recombinant M. haemofelis DnaK
ELISA to screen feline plasma. The recombinant M. haemofe-
lis DnaK was successfully applied to the ELISA format. Quan-
tities of antigen of 21.6 and 10.8 ng per well gave the best
signal-to-noise ratio. A secondary antibody dilution of 1:10,000
gave the optimal signal at around 75 min after the application
of pNPP, with wells containing a 1:20,000 secondary antibody
dilution taking considerably longer to develop an acceptable
signal. Therefore, the final protocol included the following:
recombinant M. haemofelis DnaK at 14 ng per well (equivalent
to a 1:5,000 dilution of the purified protein stock), secondary
antibody at a 1:10,000 dilution, and the reading of the plates at
75 min.
All experimental cats were negative for anti-M. haemofelis
FIG. 2. Two-dimensional electrophoresis of M. haemofelis protein
stained with Sypro ruby. The spots corresponding to DnaK (D), pgk
(P), and EF-Ts (E) are indicated by the circles. The pH orientation and
three molecular mass markers (Unstained Precision Plus Protein Stan-
dard; Bio-Rad) are indicated.
FIG. 3. One-dimensional electrophoretic gel (4 to 12%) of recom-
binant M. haemofelis DnaK stained with Coomassie blue R-250. Three
bands can be seen in the purified recombinant M. haemofelis DnaK
preparation (arrowheads); these subsequently were demonstrated us-
ing mass spectrometry to be full-length recombinant M. haemofelis
DnaK (70 kDa) and two C-terminal breakdown fragments (32 and 12
kDa). All Blue Precision Plus Protein Standard (Bio-Rad) (weights
marked for major bands) was used to estimate molecular weights.
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DnaK antibodies in preinfection plasma samples. The mean 
standard deviation OD for all of the preinfection samples was
0.059  0.012. ELISA results were considered positive at ODs
of 0.095. At 75 min, ODs obtained from the standard sample
plotted against the log of the standard dilutions was linear,
where OD  0.4, equivalent to an approximate RAL of 250.
All 10 M. haemofelis-infected cats showed a quantifiable re-
combinant M. haemofelis DnaK ELISA response at 15 dpi; at
8 dpi only unquantifiable positive (n 	 2) or negative (n 	 8)
results occurred (Table 1). The appearance of a quantifiable
antibody response coincided with the mean lowest PCV value
(Table 1). However, no correlation was detected between nadir
PCV and peak RAL (
 	0.250; P	 0.486), and there was no
correlation detected between peak hemoplasma copy number
and peak RAL (
 	 0.372; P	 0.290) for cats infected with M.
haemofelis. The “Ca. Mycoplasma haemominutum”- and “Ca.
Mycoplasma turicensis”-infected cats (n 	 3 for each) all gave
positive recombinant M. haemofelis DnaK ELISA results by 36
dpi (Table 1); however, none produced quantifiable results. All
but one of the experimental cats remained ELISA positive up
to 71 dpi. Quantitative PCR data from the experimental cats
used in this study (15) showed that they become positive by 2
dpi with M. haemofelis and “Ca. Mycoplasma haemominutum”
infection and by 8 dpi for “Ca. Mycoplasma turicensis” infec-
tion, indicating a delay of at least 6 days between qPCR pos-
itivity and the production of detectable antibodies (Fig. 5
shows representative qPCR and ELISA results).
Of the clinical samples submitted for hemoplasma qPCR,
254 had plasma samples available for analysis by ELISA. Of
these 254 samples, qPCR analysis found one to be positive for
M. haemofelis alone (0.4%), one was dual positive for M. hae-
mofelis and “Ca. Mycoplasma haemominutum” (0.4%), and 23
cats were positive for “Ca. Mycoplasma haemominutum”
alone (9.1%). None were qPCR positive for “Ca. Mycoplasma
turicensis.” The M. haemofelis-infected cat was positive (un-
quantifiable) using the ELISA, while the positive result for the
dually M. haemofelis- and “Ca. Mycoplasma haemominutum”-
infected cat was quantifiable (RAL of 1,398). Of the 23 cats
infected with “Ca. Mycoplasma haemominutum” only, 16
(70.0%) were positive; of these, five were quantifiable (RALs
of 303, 303, 414, 965, and 1,098). Of the 229 qPCR hemo-
plasma-negative samples, 61 (26.6%) were positive; of these,
four were quantifiable (RALs of 254, 294, 323, and 353).
FIG. 4. Representative Western blot of recombinant M. haemofelis
DnaK produced using plasma taken from four cats experimentally
infected with M. haemofelis before and 29 days after infection.
TABLE 1. Recombinant M. haemofelis DnaK ELISA results for the experimentally infected catsa
Cat Preinfectionscore
Score on dpi:
8 15 22 29 36 43 50 57 64 71
HF1 N (40.0) P (25.0) 1,641 (7.0) 1,455 (19.0) 410 (15.0) 574 (23.5) P (23.5) P (30.0) P (33.5) P (31.0) P (30.0)
HF2 N (44.0) N (34.0) 1,179 (17.0) 2,622 (21.0) 2,120 (17.5) 1,885 (27.0) 664 (31.0) 516 (47.0) 454 (35.0) 411 (35.0) 345 (36.0)
HF3 N (41.0) N (31.0) 1,608 (14.0) 5,297 (9.0) 2,633 (24.0) 2,558 (19.0) 1,366 (26.0) 865 (29.0) 645 (30.0) 625 (31.0) 591 (35.0)
HF4 N (41.0) N (33.5) 1,061 (18.5) 4,391 (21.0) 3,137 (23.5) 2,007 (31.0) 1,029 (34.0) 643 (35.0) 590 (35.0) 451 (32.5) 497 (38.0)
HF6 N (42.0) P (30.0) 6,277 (6.0) 9,362 (10.0) 10,725 (28.0) 9,069 (31.0) 5,165 (37.0) 2,846 (32.0) 1,793 (35.0) 1,450 (32.5) 726 (42.0)
HF7 N (43.0) N (30.0) 486 (24.0) 2,071 (25.0) 1,459 (21.0) 463 (33.5) 342 (32.0) 284 (29.0) 305 (35.0) 329 (34.0) 323 (35.0)
HF8 N (41.5) N (32.0) 6,186 (11.5) 8,342 (12.0) 3,951 (17.5) 1,532 (30.0) 884 (33.5) 503 (27.0) 441 (29.5) 407 (26.0) 424 (36.0)
HF9 N (41.5) N (28.0) 856 (7.5) 2,033 (21.0) 7,110 (17.5) 1,574 (24.0) 879 (26.5) 490 (29.0) 466 (30.0) 386 (33.5) P (33.5)
HF10 N (39.0) N (31.0) 488 (20.9) 7,859 (20.0) 11,513 (18.0) 4,011 (30.0) 1,679 (35.0) 699 (31.0) 543 (33.5) 473 (32.0) 318 (34.0)
HF12 N (41.0) N (31.0) 1,850 (17.0) 1,519 (21.5) 1,128 (20.0) 579 (25.0) 450 (35.0) 448 (35.0) 466 (39.0) 391 (36.0) 307 (45.0)
HM1 N N N P P P P P P P P
HM2 N N N N P P P P P P P
HM4 N N N N N P P P P P P
TU1 N N P P P P P P P P P
TU2 N N N P P P P P P P P
TU4 N N N N P P P P P P N
a For each time point the ELISA result was recorded as either negative (N), as an unquantifiable positive (P), or as a quantifiable positive (relative antibody level
compared to a standard). Packed cell volume (PCV) is recorded for all M. haemofelis-infected cats in parentheses, and the nadir is highlighted in boldface. None of
the “Ca. Mycoplasma haemominutum”- or “Ca. Mycoplasma turicensis”-infected cats became anemic (PCV  25%). PCV reference range, 25 to 45%.
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DISCUSSION
We have identified the dnaK, pgk, and EF-Ts genes of M.
haemofelis using the DNA sequencing of random clones from
a gDNA shotgun library and in silico analysis. We have further
shown these proteins to be immunogenic, corresponding to a
spot on a Western blot using mass spectrometry. This is similar
to findings for other mammals infected with mycoplasmas
where housekeeper proteins, such as M. suis DnaK and gly-
ceraldehyde-3-phosphate dehydrogenase and Mycoplasma my-
coides subsp. mycoides small-colony DnaK, pgk, and elongation
factors G and Tu were found to be immunogenic (3, 4).
Recombinant M. haemofelis DnaK has been expressed in E.
coli and has been shown to adsorb reactive antibodies in cats
infected with all three species of hemoplasma by both Western
blotting and ELISA, indicating cross-reactivity between the
hemoplasma species. Therefore, it is not useful in discriminat-
ing between infecting species. The relative reactivity to recom-
binant M. haemofelis DnaK on both the Western blotting and
ELISA of cats, however, varied with the infecting species; M.
haemofelis produced a greater response than “Ca. Mycoplasma
turicensis,” which in turn produced a greater response than
“Ca. Mycoplasma haemominutum.” This could be due to the
humoral immune response being directed against conserved,
hemoplasma clade-specific (8), and/or species-specific epitopes
on M. haemofelis DnaK, or a measure of the degree to which
the immune response to DnaK is triggered by the infecting
hemoplasma species due to the severity of disease. In line with
this idea, an earlier report on the hematological data acquired
from the experimental cats used in this study (15) showed that
M. haemofelis was the most pathogenic, inducing significant
anemia and the production of both cold and warm reactive
erythrocyte-bound antibodies, while “Ca. Mycoplasma haemo-
minutum” and “Ca. Mycoplasma turicensis,” although causing
a drop in RBC count, did not result in anemia or the produc-
tion of detectable erythrocyte-bound antibodies. The same
study also demonstrated that there was no significant differ-
ence in copy numbers between the M. haemofelis- and “Ca.
Mycoplasma haemominutum”-infected cats used in this study,
while the “Ca. Mycoplasma turicensis”-infected cats had sig-
nificantly lower copy numbers than both M. haemofelis- and
“Ca. Mycoplasma haemominutum”-infected cats, indicating
that differences in response to the three hemoplasma species
are not dependent on copy number alone. Additionally, our
data did not show any correlation between peak M. haemofelis
hemoplasma copy number or the nadir of PCV and peak RAL,
indicating a degree of host variability in response to infection.
The percentage of cats qPCR positive for hemoplasmas
(9.8%) in the samples submitted to the commercial laboratory
was slightly lower than those previously reported for the
United Kingdom (14.0 to 18.5%), as determined by PCR (8,
10). The finding that 31.1% of these samples were recombinant
M. haemofelis DnaK ELISA positive suggests, however, that a
significant proportion of the cats had been exposed to hemo-
plasmas despite not being qPCR positive at the time of testing.
These cats could have either cleared hemoplasma DNA from
the blood or been infected with levels of hemoplasma organ-
isms below the sensitivity limit of qPCR detection. Impor-
tantly, this study suggests that reported hemoplasma preva-
lences based on PCR in the United Kingdom, and by inference
world-wide, may have been significantly underestimated. Re-
garding the clinical samples, it is not known whether the re-
combinant M. haemofelis DnaK antibodies detected in some of
the qPCR-positive cats in this study were produced in response
to the current hemoplasma species detected by PCR or as a
result of earlier infection with a different hemoplasma species
that subsequently was cleared. The possibility of cross-reacting
antibodies generated as a result of a nonhemoplasma infection
in these cats also cannot be excluded. Interestingly, the single
clinical M. haemofelis qPCR-positive cat, which had a weakly
positive recombinant M. haemofelis DnaK ELISA result, had a
high hemoplasma load documented by qPCR (2.2 109 copies
per ml blood), which is consistent with the early humoral
response to acute infection seen around 8 dpi in the experi-
mentally infected cats. In contrast, the dually M. haemofelis-
and “Ca. Mycoplasma haemominutum”-infected cat had mod-
erate and low hemoplasma species loads (4.4  107 copies M.
haemofelis and 200 copies “Ca. Mycoplasma haemominutum”
per ml blood) but a quantifiable recombinant M. haemofelis
DnaK ELISA-positive result, which is consistent with the es-
tablished humoral response to M. haemofelis infection seen
from 15 dpi onwards in the experimentally infected cats.
This is the first description of the use of shotgun clone-
derived genomic sequences in the identification of an immu-
nogenic protein of a feline hemoplasma from 2D proteome
analysis. This protein subsequently was expressed and applied
FIG. 5. Mycoplasma haemofelis qPCR results (square boxes, dotted
line) and recombinant M. haemofelis DnaK ELISA relative antibody
levels (diamond boxes, dashed line) from two representative cats: HF4
(A) and HF12 (B). The horizontal dashed line (W) represents the
quantification minimum limit of both assays.
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to the serological study of cats experimentally infected with
hemoplasmas, and clinical samples were submitted for diag-
nostic qPCR hemoplasma testing. Further testing is required
to clarify its use in non-SPF-derived cats and assess any sero-
logical cross-reactivity as a result of other chronic bacterial
infections, such as Bartonella henselae, Chlamydophila felis, and
Mycoplasma felis. In the future, the ELISA should be applied
to experimentally infected cats beyond the acute infection pe-
riod to determine whether recombinant M. haemofelis DnaK
antibodies persist in chronically infected cats and/or in cats
that generate qPCR-negative results following the suspected
clearance of infection.
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